713 related articles for article (PubMed ID: 12417659)
21. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.
Leroy K; Bretteville A; Schindowski K; Gilissen E; Authelet M; De Decker R; Yilmaz Z; Buée L; Brion JP
Am J Pathol; 2007 Sep; 171(3):976-92. PubMed ID: 17690183
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J
Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690
[TBL] [Abstract][Full Text] [Related]
23. Cryo-EM structures of tau filaments from the brains of mice transgenic for human mutant P301S Tau.
Schweighauser M; Murzin AG; Macdonald J; Lavenir I; Crowther RA; Scheres SHW; Goedert M
Acta Neuropathol Commun; 2023 Oct; 11(1):160. PubMed ID: 37798679
[TBL] [Abstract][Full Text] [Related]
24. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.
Tatebayashi Y; Miyasaka T; Chui DH; Akagi T; Mishima K; Iwasaki K; Fujiwara M; Tanemura K; Murayama M; Ishiguro K; Planel E; Sato S; Hashikawa T; Takashima A
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13896-901. PubMed ID: 12368474
[TBL] [Abstract][Full Text] [Related]
25. Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice.
Ohia-Nwoko O; Montazari S; Lau YS; Eriksen JL
Mol Neurodegener; 2014 Nov; 9():54. PubMed ID: 25432085
[TBL] [Abstract][Full Text] [Related]
26. Lack of exacerbation of neurodegeneration in a double transgenic mouse model of mutant LRRK2 and tau.
Mikhail F; Calingasan N; Parolari L; Subramanian A; Yang L; Flint Beal M
Hum Mol Genet; 2015 Jun; 24(12):3545-56. PubMed ID: 25804954
[TBL] [Abstract][Full Text] [Related]
27. Transgenic mouse models of tauopathies: prospects for animal models of Pick's disease.
Lee VM; Trojanowski JQ
Neurology; 2001 Jun; 56(11 Suppl 4):S26-30. PubMed ID: 11402147
[TBL] [Abstract][Full Text] [Related]
28. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.
Vega IE; Cui L; Propst JA; Hutton ML; Lee G; Yen SH
Brain Res Mol Brain Res; 2005 Aug; 138(2):135-44. PubMed ID: 15913839
[TBL] [Abstract][Full Text] [Related]
29. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
[TBL] [Abstract][Full Text] [Related]
30. Cortical neuronal and glial pathology in TgTauP301L transgenic mice: neuronal degeneration, memory disturbance, and phenotypic variation.
Murakami T; Paitel E; Kawarabayashi T; Ikeda M; Chishti MA; Janus C; Matsubara E; Sasaki A; Kawarai T; Phinney AL; Harigaya Y; Horne P; Egashira N; Mishima K; Hanna A; Yang J; Iwasaki K; Takahashi M; Fujiwara M; Ishiguro K; Bergeron C; Carlson GA; Abe K; Westaway D; St George-Hyslop P; Shoji M
Am J Pathol; 2006 Oct; 169(4):1365-75. PubMed ID: 17003492
[TBL] [Abstract][Full Text] [Related]
31. Cell-cycle markers in a transgenic mouse model of human tauopathy: increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1.
Delobel P; Lavenir I; Ghetti B; Holzer M; Goedert M
Am J Pathol; 2006 Mar; 168(3):878-87. PubMed ID: 16507903
[TBL] [Abstract][Full Text] [Related]
32. Transgenic zebrafish model of neurodegeneration.
Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
[TBL] [Abstract][Full Text] [Related]
33. Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau.
Tanemura K; Akagi T; Murayama M; Kikuchi N; Murayama O; Hashikawa T; Yoshiike Y; Park JM; Matsuda K; Nakao S; Sun X; Sato S; Yamaguchi H; Takashima A
Neurobiol Dis; 2001 Dec; 8(6):1036-45. PubMed ID: 11741399
[TBL] [Abstract][Full Text] [Related]
34. Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice.
Spittaels K; Van den Haute C; Van Dorpe J; Geerts H; Mercken M; Bruynseels K; Lasrado R; Vandezande K; Laenen I; Boon T; Van Lint J; Vandenheede J; Moechars D; Loos R; Van Leuven F
J Biol Chem; 2000 Dec; 275(52):41340-9. PubMed ID: 11007782
[TBL] [Abstract][Full Text] [Related]
35. Mutations causing neurodegenerative tauopathies.
Goedert M; Jakes R
Biochim Biophys Acta; 2005 Jan; 1739(2-3):240-50. PubMed ID: 15615642
[TBL] [Abstract][Full Text] [Related]
36. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia.
García-Cabrero AM; Guerrero-López R; Giráldez BG; Llorens-Martín M; Avila J; Serratosa JM; Sánchez MP
Neurobiol Dis; 2013 Oct; 58():200-8. PubMed ID: 23774255
[TBL] [Abstract][Full Text] [Related]
37. Ordered Assembly of Tau Protein and Neurodegeneration.
Goedert M; Spillantini MG
Adv Exp Med Biol; 2019; 1184():3-21. PubMed ID: 32096024
[TBL] [Abstract][Full Text] [Related]
38. Transmission and spreading of tauopathy in transgenic mouse brain.
Clavaguera F; Bolmont T; Crowther RA; Abramowski D; Frank S; Probst A; Fraser G; Stalder AK; Beibel M; Staufenbiel M; Jucker M; Goedert M; Tolnay M
Nat Cell Biol; 2009 Jul; 11(7):909-13. PubMed ID: 19503072
[TBL] [Abstract][Full Text] [Related]
39. [Animal models of tauopathies].
Higuchi M
Rinsho Shinkeigaku; 2006 Nov; 46(11):928-30. PubMed ID: 17432223
[TBL] [Abstract][Full Text] [Related]
40. Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration.
Piao YS; Hayashi S; Hasegawa M; Wakabayashi K; Yamada M; Yoshimoto M; Ishikawa A; Iwatsubo T; Takahashi H
Acta Neuropathol; 2001 Mar; 101(3):285-93. PubMed ID: 11307630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
